2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 449.180 | 408.736 | 304.944 | 285.339 | 282.734 | 246.591 | 299.115 | 246.344 | 283.725 | 246.181 |
Total Income - EUR | 449.410 | 409.479 | 307.249 | 286.446 | 283.480 | 246.870 | 299.686 | 246.780 | 283.906 | 246.462 |
Total Expenses - EUR | 431.698 | 425.213 | 302.024 | 284.521 | 278.557 | 246.047 | 286.736 | 245.475 | 280.047 | 260.587 |
Gross Profit/Loss - EUR | 17.712 | -15.734 | 5.225 | 1.925 | 4.922 | 823 | 12.950 | 1.304 | 3.858 | -14.125 |
Net Profit/Loss - EUR | 14.551 | -16.144 | 5.225 | 1.615 | 3.488 | 141 | 11.035 | 635 | 2.784 | -14.125 |
Employees | 5 | 5 | 7 | 6 | 0 | 4 | 4 | 4 | 4 | 4 |
Check the financial reports for the company - Farmacia Horbaniuc Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 43.320 | 42.098 | 40.127 | 50.007 | 46.880 | 43.826 | 40.890 | 44.248 | 41.980 | 39.837 |
Current Assets | 264.559 | 156.592 | 106.516 | 121.873 | 118.767 | 118.851 | 132.524 | 109.960 | 114.615 | 94.776 |
Inventories | 124.929 | 90.746 | 72.485 | 72.642 | 58.506 | 78.140 | 75.379 | 69.463 | 70.899 | 53.805 |
Receivables | 122.487 | 44.530 | 14.219 | 41.229 | 49.060 | 35.738 | 43.201 | 36.073 | 37.448 | 33.861 |
Cash | 17.143 | 21.316 | 19.811 | 8.002 | 11.201 | 4.973 | 13.945 | 4.424 | 6.268 | 7.111 |
Shareholders Funds | 82.113 | 66.807 | 53.963 | 67.510 | 69.759 | 68.549 | 78.305 | 83.865 | 62.697 | 48.382 |
Social Capital | 72 | 225 | 223 | 9.851 | 9.670 | 9.483 | 9.324 | 9.117 | 9.145 | 9.118 |
Debts | 226.117 | 132.448 | 92.947 | 104.804 | 96.316 | 94.521 | 95.109 | 70.342 | 93.898 | 86.805 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "6820 - 6820" | |||||||||
CAEN Financial Year |
4773
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Farmacia Horbaniuc Srl